vs

Side-by-side financial comparison of CABOT CORP (CBT) and ON Semiconductor (ON). Click either name above to swap in a different company.

ON Semiconductor is the larger business by last-quarter revenue ($1.6B vs $849.0M, roughly 1.8× CABOT CORP). ON Semiconductor runs the higher net margin — 16.4% vs 8.6%, a 7.8% gap on every dollar of revenue. On growth, ON Semiconductor posted the faster year-over-year revenue change (-10.0% vs -11.1%). ON Semiconductor produced more free cash flow last quarter ($372.4M vs $57.0M). Over the past eight quarters, CABOT CORP's revenue compounded faster (-8.7% CAGR vs -12.3%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Fairchild Semiconductor International, Inc. was an American semiconductor company based in San Jose, California. It was founded in 1957 as a division of Fairchild Camera and Instrument by the "traitorous eight" who defected from Shockley Semiconductor Laboratory. It became a pioneer in the manufacturing of transistors and of integrated circuits. Schlumberger bought the firm in 1979 and sold it to National Semiconductor in 1987; Fairchild was spun off as an independent company again in 1997. I...

CBT vs ON — Head-to-Head

Bigger by revenue
ON
ON
1.8× larger
ON
$1.6B
$849.0M
CBT
Growing faster (revenue YoY)
ON
ON
+1.1% gap
ON
-10.0%
-11.1%
CBT
Higher net margin
ON
ON
7.8% more per $
ON
16.4%
8.6%
CBT
More free cash flow
ON
ON
$315.4M more FCF
ON
$372.4M
$57.0M
CBT
Faster 2-yr revenue CAGR
CBT
CBT
Annualised
CBT
-8.7%
-12.3%
ON

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CBT
CBT
ON
ON
Revenue
$849.0M
$1.6B
Net Profit
$73.0M
$255.0M
Gross Margin
24.9%
37.9%
Operating Margin
15.2%
17.0%
Net Margin
8.6%
16.4%
Revenue YoY
-11.1%
-10.0%
Net Profit YoY
-21.5%
-32.9%
EPS (diluted)
$1.37
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
ON
ON
Q4 25
$849.0M
$1.6B
Q3 25
$899.0M
$1.5B
Q2 25
$923.0M
$1.4B
Q1 25
$936.0M
Q4 24
$955.0M
$1.7B
Q3 24
$1.0B
$1.8B
Q2 24
$1.0B
$1.7B
Q1 24
$1.0B
$1.9B
Net Profit
CBT
CBT
ON
ON
Q4 25
$73.0M
$255.0M
Q3 25
$43.0M
$170.3M
Q2 25
$101.0M
$-486.1M
Q1 25
$94.0M
Q4 24
$93.0M
$379.9M
Q3 24
$137.0M
$401.7M
Q2 24
$109.0M
$338.2M
Q1 24
$84.0M
$453.0M
Gross Margin
CBT
CBT
ON
ON
Q4 25
24.9%
37.9%
Q3 25
24.5%
37.6%
Q2 25
26.4%
20.3%
Q1 25
25.7%
Q4 24
24.6%
45.2%
Q3 24
24.0%
45.4%
Q2 24
25.2%
45.2%
Q1 24
24.1%
45.8%
Operating Margin
CBT
CBT
ON
ON
Q4 25
15.2%
17.0%
Q3 25
15.2%
13.2%
Q2 25
18.1%
-39.7%
Q1 25
17.3%
Q4 24
16.2%
23.7%
Q3 24
15.0%
25.3%
Q2 24
16.9%
22.4%
Q1 24
15.3%
28.2%
Net Margin
CBT
CBT
ON
ON
Q4 25
8.6%
16.4%
Q3 25
4.8%
11.6%
Q2 25
10.9%
-33.6%
Q1 25
10.0%
Q4 24
9.7%
22.1%
Q3 24
13.7%
22.8%
Q2 24
10.7%
19.5%
Q1 24
8.2%
24.3%
EPS (diluted)
CBT
CBT
ON
ON
Q4 25
$1.37
$0.63
Q3 25
$0.80
$0.41
Q2 25
$1.86
$-1.15
Q1 25
$1.69
Q4 24
$1.67
$0.88
Q3 24
$2.41
$0.93
Q2 24
$1.94
$0.78
Q1 24
$1.49
$1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
ON
ON
Cash + ST InvestmentsLiquidity on hand
$230.0M
$2.9B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$1.6B
$7.9B
Total Assets
$3.8B
$13.0B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
ON
ON
Q4 25
$230.0M
$2.9B
Q3 25
$258.0M
$2.8B
Q2 25
$239.0M
$3.0B
Q1 25
$213.0M
Q4 24
$183.0M
$3.0B
Q3 24
$223.0M
$2.8B
Q2 24
$197.0M
$2.7B
Q1 24
$206.0M
$2.6B
Total Debt
CBT
CBT
ON
ON
Q4 25
$3.4B
Q3 25
$1.1B
$3.4B
Q2 25
$3.4B
Q1 25
Q4 24
$3.4B
Q3 24
$1.1B
$3.4B
Q2 24
$3.4B
Q1 24
$3.4B
Stockholders' Equity
CBT
CBT
ON
ON
Q4 25
$1.6B
$7.9B
Q3 25
$1.6B
$7.9B
Q2 25
$1.5B
$8.0B
Q1 25
$1.4B
Q4 24
$1.4B
$8.8B
Q3 24
$1.4B
$8.6B
Q2 24
$1.3B
$8.3B
Q1 24
$1.4B
$8.1B
Total Assets
CBT
CBT
ON
ON
Q4 25
$3.8B
$13.0B
Q3 25
$3.8B
$13.1B
Q2 25
$3.8B
$13.3B
Q1 25
$3.8B
Q4 24
$3.6B
$14.1B
Q3 24
$3.7B
$13.9B
Q2 24
$3.6B
$13.7B
Q1 24
$3.6B
$13.5B
Debt / Equity
CBT
CBT
ON
ON
Q4 25
0.43×
Q3 25
0.70×
0.43×
Q2 25
0.42×
Q1 25
Q4 24
0.38×
Q3 24
0.75×
0.39×
Q2 24
0.41×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
ON
ON
Operating Cash FlowLast quarter
$126.0M
$418.7M
Free Cash FlowOCF − Capex
$57.0M
$372.4M
FCF MarginFCF / Revenue
6.7%
24.0%
Capex IntensityCapex / Revenue
8.1%
3.0%
Cash ConversionOCF / Net Profit
1.73×
1.64×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
ON
ON
Q4 25
$126.0M
$418.7M
Q3 25
$219.0M
$184.3M
Q2 25
$249.0M
$602.3M
Q1 25
$73.0M
Q4 24
$124.0M
$579.7M
Q3 24
$204.0M
$465.8M
Q2 24
$207.0M
$362.2M
Q1 24
$176.0M
$498.7M
Free Cash Flow
CBT
CBT
ON
ON
Q4 25
$57.0M
$372.4M
Q3 25
$155.0M
$106.1M
Q2 25
$188.0M
$454.7M
Q1 25
$1.0M
Q4 24
$47.0M
$434.8M
Q3 24
$112.0M
$293.6M
Q2 24
$155.0M
$207.7M
Q1 24
$133.0M
$276.3M
FCF Margin
CBT
CBT
ON
ON
Q4 25
6.7%
24.0%
Q3 25
17.2%
7.2%
Q2 25
20.4%
31.5%
Q1 25
0.1%
Q4 24
4.9%
25.2%
Q3 24
11.2%
16.7%
Q2 24
15.3%
12.0%
Q1 24
13.1%
14.8%
Capex Intensity
CBT
CBT
ON
ON
Q4 25
8.1%
3.0%
Q3 25
7.1%
5.3%
Q2 25
6.6%
10.2%
Q1 25
7.7%
Q4 24
8.1%
8.4%
Q3 24
9.2%
9.8%
Q2 24
5.1%
8.9%
Q1 24
4.2%
11.9%
Cash Conversion
CBT
CBT
ON
ON
Q4 25
1.73×
1.64×
Q3 25
5.09×
1.08×
Q2 25
2.47×
Q1 25
0.78×
Q4 24
1.33×
1.53×
Q3 24
1.49×
1.16×
Q2 24
1.90×
1.07×
Q1 24
2.10×
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

ON
ON

Industrial Segment$426.3M27%
Other End Markets Segment$337.3M22%
Intelligent Sensing Segments$284.0M18%
Direct Customers$282.4M18%
Intelligent Sensing Group$230.0M15%

Related Comparisons